Literature DB >> 24632221

Conveying a probabilistic genetic test result to families with an inherited heart disease.

Jodie Ingles1, Christopher Semsarian2.   

Abstract

The evolution of genetic testing in the past few years has been astounding. In a matter of only a few years, we now have comprehensive gene tests comprising vast panels of "cardiac" genes, whole exome sequencing (the entire coding region) and even whole genome sequencing (the entire genome). Making the call as to whether a DNA variant is causative or benign is difficult and the focus of intense research efforts. In most cases, the final answer will not be a simple yes/no outcome but rather a graded continuum of pathogenicity. This allows classification of variants in a more probabilistic way. How we convey this to a patient is the challenge, and certainly shines a spotlight on the important skills of the cardiac genetic counselor. This is an exciting step forward, but the overwhelming complexity of the information generated from these tests means our current practices of conveying genetic information to the family must be carefully considered. Despite the challenges, a genetic diagnosis in a family has great benefit both in reassuring unaffected family members and removing the need for lifetime clinical surveillance. The multidisciplinary specialized clinic model, incorporating genetic counselors, cardiologists and geneticists, provides the ideal framework for ensuring the best possible care for genetic heart disease families.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic counseling; Genetic heart disease; Multidisciplinary team; Next generation sequencing

Mesh:

Year:  2014        PMID: 24632221     DOI: 10.1016/j.hrthm.2014.03.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  14 in total

1.  Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.

Authors:  Charlotte Burns; Laura Yeates; Catherine Spinks; Christopher Semsarian; Jodie Ingles
Journal:  Eur J Hum Genet       Date:  2017-05-03       Impact factor: 4.246

2.  Clinical Cardiovascular Genetic Counselors Take a Leading Role in Team-based Variant Classification.

Authors:  Chloe Reuter; Megan E Grove; Kate Orland; Katherine Spoonamore; Colleen Caleshu
Journal:  J Genet Couns       Date:  2017-12-12       Impact factor: 2.537

Review 3.  Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies.

Authors:  Han-Chih Hencher Lee; Chor-Kwan Ching
Journal:  Clin Biochem Rev       Date:  2019-11

Review 4.  Genetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians.

Authors:  Melanie Care; Vijay Chauhan; Danna Spears
Journal:  Curr Cardiol Rep       Date:  2017-08-16       Impact factor: 2.931

Review 5.  Precision Cardiovascular Medicine: State of Genetic Testing.

Authors:  John R Giudicessi; Iftikhar J Kullo; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2017-04       Impact factor: 7.616

6.  Perceptions of genetic variant reclassification in patients with inherited cardiac disease.

Authors:  Eugene K Wong; Kirsten Bartels; Julie Hathaway; Charlotte Burns; Laura Yeates; Christopher Semsarian; Andrew D Krahn; Alice Virani; Jodie Ingles
Journal:  Eur J Hum Genet       Date:  2019-03-21       Impact factor: 4.246

7.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

8.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  J Arrhythm       Date:  2021-04-08

9.  Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience.

Authors:  Austin Bland; Elizabeth A Harrington; Kyla Dunn; Mitchel Pariani; Julia C K Platt; Megan E Grove; Colleen Caleshu
Journal:  Genet Med       Date:  2017-12-14       Impact factor: 8.822

Review 10.  The Current Landscape of Genetic Testing in Cardiovascular Malformations: Opportunities and Challenges.

Authors:  Benjamin J Landis; Stephanie M Ware
Journal:  Front Cardiovasc Med       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.